We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Avian Influenza Virus Shows Pandemic Potential

By HospiMedica International staff writers
Posted on 24 Jul 2013
Several qualities that characterize the Chinese H7N9 avian influenza virus suggest to epidemiologists that this strain has the potential to trigger a worldwide flu pandemic.

The recent sporadic infections of humans in China with a previously unrecognized avian Influenza A virus of the H7N9 subtype have caused concern owing to the appreciable case fatality rate associated with these infections (more than 25%), potential instances of human-to-human transmission, and the lack of pre-existing immunity among humans to viruses of this subtype. More...


Investigators at the University of Wisconsin (Madison, USA) and their colleagues at the University of Tokyo (Japan) characterized two early human H7N9 isolates, A/Anhui/1/2013 and A/Shanghai/1/2013.

In mice, Anhui/1 and Shanghai/1 were more pathogenic than a control avian H7N9 virus (A/duck/Gunma/466/2011) and a representative pandemic 2009 H1N1 virus (A/California/4/2009). Anhui/1, Shanghai/1 and Dk/GM466 replicated well in the nasal turbinates (scrolled spongy bones of the nasal passage) of ferrets. Anhui/1 transmitted through respiratory droplets in one of three pairs of ferrets. Ferrets infect one another with influenza virus through coughing and sneezing and are a standard model for studies of influenza in mammals.

In nonhuman primates, Anhui/1 and Dk/GM466 replicated efficiently in the upper and lower respiratory tracts, whereas the replication of conventional human influenza viruses is typically restricted to the upper respiratory tract of infected primates. Anhui/1 was found to be less sensitive in mice to neuraminidase inhibitors than a pandemic H1N1 2009 virus, although both viruses were equally susceptible to an experimental antiviral polymerase inhibitor.

The findings obtained during this study, especially the ability of the virus to replicate in mice, ferrets, and nonhuman primates and the limited transmissibility in ferrets suggest that H7N9 viruses may have pandemic potential.

"H7N9 viruses have several features typically associated with human influenza viruses and therefore possess pandemic potential and need to be monitored closely," said senior author Dr. Yoshihiro Kawaoka, professor of virology at the University of Wisconsin. "H7N9 viruses combine several features of pandemic influenza viruses, that is, their ability to bind to and replicate in human cells and the ability to transmit via respiratory droplets. If H7N9 viruses acquire the ability to transmit efficiently from person to person, a worldwide outbreak is almost certain since humans lack protective immune responses to these types of viruses."

The study was published in the July 10, 2013, online edition of the journal Nature.

Related Links:

University of Wisconsin
University of Tokyo



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.